Should healthcare workers have the swine flu vaccine?

BMJ (Online)

Volumn 339, Issue 7721, 2009, Pages 584-

  Jordan, Rachel ^a   Hayward, Andrew ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ABSENTEEISM; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; EDITORIAL; FATALITY; GOVERNMENT; GROUPS BY AGE; GUILLAIN BARRE SYNDROME; HEALTH CARE PERSONNEL; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; MORTALITY; NURSE; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; SWINE; UNITED KINGDOM; VACCINATION; WORLD HEALTH ORGANIZATION;

HEALTH PERSONNEL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 70349088226     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b3398     Document Type: Editorial

References (12)

1. Department of Health. Letter from office of David Nicholson chief executive of the NHS in England, 13 August 2009. , www.dh.gov.uk/prod-consum-dh/ groups/dh-digitalassets/documents/digitalasset/dh-104309.pdf.
2. Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 1999;281:908-913[Abstract/Free Full Text] (Pubitemid 29124634)
3. Hayward AC, Harling R, Wetten S, Johnson AM, Munro S, Smedley J, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ 2006;333:1241-1247[Abstract/Free Full Text] (Pubitemid 46032352)
4. Weingarten S, Staniloff H, Ault M, Miles P, Bamberger M, Meyer RD. Do hospital employees benefit from the influenza vaccine? A placebo-controlled clinical trial. J Gen Intern Med 1988;3:32-37[Web of Science][Medline] (Pubitemid 18166218)
5. Begum F, Pebody R; for the Health Protection Agency. Summary report: influenza vaccination uptake for healthcare workers (HCWs) in England. Winter season 2008/2009. , www.immunisation.nhs.uk/publications/FluVaccineUptake-HCW- Winter0809.pdf.
6. Pareek M, Clark T, Dillon H, Kumar R, Stephenson I. Willingness of healthcare workers to accept voluntary stockpiled H5N1 vaccine in advance of pandemic activity. Vaccine 2009;27:1242-1247 [CrossRef][Web of Science][Medline]
7. Chor JSY, Ngai KLK, Goggins WB, Wong MCS, Wong SYS, Lee N, et al. Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. BMJ 2009;339:b3391.[Abstract/Free Full Text]
8. European Medicines Agency. Press release: review of pandemic vaccines underway. 2009. www.emea.europa.eu/pdfs/human/press/pr/46856809en.pdf.
9. Leroux-Roels I, Borkowski A, Vanwolleghem T, Dramé M, Clement F, Hons E, et al. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 2007;370:580-589[CrossRef][Web of Science][Medline] (Pubitemid 47247854)
10. Breman JG, Hayner NS. Guillain-Barré syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977. Am J Epidemiol 1984;119:880-889[Abstract/Free Full Text]
11. Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine 2009;27:2114-2120[CrossRef][Web of Science][Medline]
12. Stowe J, Andrews N, Wise L, Miller E. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenza-like illness using the United Kingdom general practice research database. Am J Epidemiol 2009;169:382-388[Abstract/Free Full Text]